HPV at non cervical sites - do we need different markers?
Andy Feber presented this lecture at the workshop on biomarkers at the IFCPC 2014
Understanding the pathophysiology of genital tract intraepithelial neoplasia is key to the management of these conditions. Molecular markers might be helpful in selection lesions which are true cancer precursos. Andy explores their use for non cervical disease.